Singapore’s NSV raises $53M for inaugural biotech fund, targeting US, Asia
NeoSci Ventures (NSV), a venture builder and investor with offices in Singapore, Taiwan and the United States, has raised S$70 million ($53 million) for its inaugural institutional venture fund.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
